Use of bacterium for manufacture of a vaccine

Abstract

The present inventon relates to the use of live attenuated bacteria for the manufacture of a vaccine for submucosal administration.

1 ) Use of a live attenuated bacterium for the manufacture of a vaccine for submucosal administration.  
     
     
         2 ) Use according to  claim 1 , characterised in that the vaccine is for administration in the submucosa of the labiae.  
     
     
         3 ) Use according to  claim 1  or  2 , characterised in that the live attenuated bacterium is an attenuated form of a horse pathogenic bacterium.  
     
     
         4 ) Use according to  claim 3 ,characterised in that the live attenuated bacterium is selected from the group of bacteria comprising  Streptococcus equi, Streptococcus zooepidemicus, Rhodococcus equi, Corynebacterium pseudotuberculosis, Pseudomonas mallel, Actinobacillus equili  and  Pasteurella multocida.    
     
     
         5 ) Use according to  claim 4 , characterised in that the live attenuated bacterium is of the species  Streptococcus equi  and/or  Streptococcus zooepidemicus.